Associated Papers
Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies.
Carreau C et al.
Journal of Neurology, Neurosurgery, and Psychiatry, 2020
A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatment.
Carreau C et al.
Annals of Clinical and Translational Neurology, 2020
Select a paper to view details